Home > Qtrly Results > BIOCON

BIOCON
Quarterly Results Analysis [Sep2025]

BIOCON is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for BIOCON
Please provide your vote to see the results

BIOCON Quarterly Results

Consolidated Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
UnAudited
Revenues ₹4,296 Cr ₹3,942 Cr ₹4,417 Cr ₹3,821 Cr ₹3,590 Cr ₹3,433 Cr ₹3,917 Cr ₹3,954 Cr
Expenses ₹3,460 Cr ₹3,193 Cr ₹3,339 Cr ₹3,070 Cr ₹2,905 Cr ₹2,813 Cr ₹3,001 Cr ₹3,027 Cr
Operating Income ₹835 Cr ₹749 Cr ₹1,078 Cr ₹752 Cr ₹685 Cr ₹620 Cr ₹916 Cr ₹927 Cr
Other Income ₹93 Cr ₹80 Cr ₹37 Cr ₹35 Cr ₹33 Cr ₹1,135 Cr ₹49 Cr ₹566 Cr
Interest ₹272 Cr ₹277 Cr ₹212 Cr ₹223 Cr ₹226 Cr ₹236 Cr ₹227 Cr ₹267 Cr
Depreciation ₹473 Cr ₹455 Cr ₹436 Cr ₹425 Cr ₹420 Cr ₹405 Cr ₹407 Cr ₹415 Cr
Profit Before Tax ₹171 Cr ₹97 Cr ₹487 Cr ₹156 Cr ₹98 Cr ₹1,146 Cr ₹322 Cr ₹832 Cr
Profit After Tax ₹133 Cr ₹89 Cr ₹459 Cr ₹81 Cr ₹27 Cr ₹862 Cr ₹226 Cr ₹777 Cr
EPS ₹0.63 ₹0.23 ₹2.87 ₹0.21 ₹-0.13 ₹5.49 ₹1.13 ₹5.50
Industry Peers & Returns1W1M1Y
BIOCON -2.9% -6.5% -1.7%
SUN PHARMACEUTICAL INDUSTRIES -6.8% -7.6% -4.7%
DIVIS LABORATORIES -6.6% -5.8% 4.5%
CIPLA -4.8% -8.1% -3.9%
TORRENT PHARMACEUTICALS 0.9% 5.7% 27.3%
DR REDDYS LABORATORIES -2% -8.8% -12.9%
MANKIND PHARMA -4% -0.9% -18.4%
ZYDUS LIFESCIENCES -3% -4.5% -10.5%
LUPIN -0.5% 2.3% 2.4%

BIOCON Quarterly Revenues

Revenues
Q-o-Q

8.97 %

Y-o-Y

19.64 %

Quarters Revenues % Change
Sep2025 ₹4,296 Cr
8.97
Jun2025 ₹3,942 Cr
-10.76
Mar2025 ₹4,417 Cr
15.59
Dec2024 ₹3,821 Cr
6.43
Sep2024 ₹3,590 Cr
4.59
Jun2024 ₹3,433 Cr
-12.36
Mar2024 ₹3,917 Cr
-0.93
Dec2023 ₹3,954 Cr -

BIOCON Quarterly Operating Profit

Operating Profit
Q-o-Q

11.55 %

Y-o-Y

21.89 %

Quarters Operating Profit % Change
Sep2025 ₹835 Cr
11.55
Jun2025 ₹749 Cr
-30.54
Mar2025 ₹1,078 Cr
43.42
Dec2024 ₹752 Cr
9.69
Sep2024 ₹685 Cr
10.48
Jun2024 ₹620 Cr
-32.26
Mar2024 ₹916 Cr
-1.18
Dec2023 ₹927 Cr -
Operating Margins
Q-o-Q

2.37 %

Y-o-Y

1.89 %

Quarters Operating Margin% % Change
Sep2025 19.45%
2.37
Jun2025 19%
-22.16
Mar2025 24.41%
24.10
Dec2024 19.67%
3.04
Sep2024 19.09%
5.64
Jun2024 18.07%
-22.71
Mar2024 23.38%
-0.26
Dec2023 23.44% -

BIOCON Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

48.88 %

Y-o-Y

390.04 %

Quarters Profit After Tax % Change
Sep2025 ₹133 Cr
48.88
Jun2025 ₹89 Cr
-80.58
Mar2025 ₹459 Cr
466.46
Dec2024 ₹81 Cr
199.26
Sep2024 ₹27 Cr
-96.86
Jun2024 ₹862 Cr
282.00
Mar2024 ₹226 Cr
-70.98
Dec2023 ₹777 Cr -
PAT Margins
Q-o-Q

36.73 %

Y-o-Y

312.00 %

Quarters PAT Margin(%) % Change
Sep2025 3.09 %
36.73
Jun2025 2.26 %
-78.27
Mar2025 10.4 %
390.57
Dec2024 2.12 %
182.67
Sep2024 0.75 %
-97.01
Jun2024 25.1 %
335.76
Mar2024 5.76 %
-70.70
Dec2023 19.66 % -

BIOCON Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

173.91 %

Y-o-Y

Positive

Quarters EPS % Change
Sep2025 ₹0.63
173.91
Jun2025 ₹0.23
-91.99
Mar2025 ₹2.87
1,266.67
Dec2024 ₹0.21
Positive
Sep2024 ₹-0.13
Negative
Jun2024 ₹5.49
385.84
Mar2024 ₹1.13
-79.45
Dec2023 ₹5.5 -

You may also like the below Video Courses